[go: up one dir, main page]

ES2174075T3 - Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas. - Google Patents

Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas.

Info

Publication number
ES2174075T3
ES2174075T3 ES96919473T ES96919473T ES2174075T3 ES 2174075 T3 ES2174075 T3 ES 2174075T3 ES 96919473 T ES96919473 T ES 96919473T ES 96919473 T ES96919473 T ES 96919473T ES 2174075 T3 ES2174075 T3 ES 2174075T3
Authority
ES
Spain
Prior art keywords
labeled
produce
methods
biochemical compounds
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96919473T
Other languages
English (en)
Inventor
Jonathan M Brown
F C Thomas Allnutt
Hao Chen
Richard Radmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Martek Biosciences Corp
Original Assignee
Martek Biosciences Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Martek Biosciences Corp filed Critical Martek Biosciences Corp
Application granted granted Critical
Publication of ES2174075T3 publication Critical patent/ES2174075T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047—Simultaneous synthesis of different peptide species; Peptide libraries

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Peptides Or Proteins (AREA)

Abstract

LIBRERIAS DE COMBINACION DE COMPUESTOS BIOQUIMICOS MARCADOS Y METODOS DE PRODUCCION DE DICHAS LIBRERIAS DE COMBINACION QUE CONSTAN DE LOS PASOS DE PRODUCIR UNIDADES INDIVIDUALES MARCADAS, LA COMBINACION DE AL MENOS DOS UNIDADES MARCADAS PARA PRODUCIR UN COMPUESTO BIOQUIMICO MARCADO, Y LA REPETICION DE ESTE PROCESO AL MENOS EN UNA OCASION PARA PRODUCIR UNA LIBRERIA DE COMBINACION DE COMPUESTOS BIOQUIMICOS MARCADOS. ADEMAS, SE PRESENTAN LOS METODOS PARA DETERMINAR LA CONFORMACION DE UN COMPUESTO BIOQUIMICO QUE CONSISTEN EN LA PRODUCCION DE UNA LIBRERIA DE COMBINACION DE COMPUESTOS BIOQUIMICOS MARCADOS, LA PUESTA EN CONTACTO DE LA LIBRERIA DE COMBINACION DE COMPUESTOS BIOQUIMICOS MARCADOS CON UNA MOLECULA DEL RECEPTOR DIANA DE MODO QUE EL COMPUESTO BIOQUIMICO MARCADO SELECCIONADO SE UNA A LA MOLECULA DEL RECEPTOR DIANA, Y LA DETERMINACION DE LA CONFORMACION DEL COMPUESTO BIOQUIMICO MARCADO SELECCIONADO CUANDO SE UNE A LA MOLECULA DEL RECEPTOR.
ES96919473T 1995-06-21 1996-06-13 Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas. Expired - Lifetime ES2174075T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US49330095A 1995-06-21 1995-06-21

Publications (1)

Publication Number Publication Date
ES2174075T3 true ES2174075T3 (es) 2002-11-01

Family

ID=23959668

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96919473T Expired - Lifetime ES2174075T3 (es) 1995-06-21 1996-06-13 Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas.

Country Status (11)

Country Link
US (1) US5741713A (es)
EP (1) EP0839152B1 (es)
JP (1) JPH11509086A (es)
AT (1) ATE214396T1 (es)
AU (1) AU6180696A (es)
CA (1) CA2225313A1 (es)
DE (1) DE69619825T2 (es)
DK (1) DK0839152T3 (es)
ES (1) ES2174075T3 (es)
PT (1) PT839152E (es)
WO (1) WO1997000887A1 (es)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1073707A4 (en) * 1998-04-30 2002-03-13 Mirus Corp TECHNIQUE FOR MANUFACTURING A COMPOUND BY FORMING A POLYMER FROM A MATRIX DRUG
AU2105601A (en) * 1999-12-17 2001-06-25 Maxygen, Inc. Methods for parallel detection of compositions having desired characteristics bymeans of mri spectroscopy
JP5305553B2 (ja) 2000-10-12 2013-10-02 ユニバーシティー オブ ロチェスター 癌細胞の増殖を阻害する組成物
US7367155B2 (en) 2000-12-20 2008-05-06 Monsanto Technology Llc Apparatus and methods for analyzing and improving agricultural products
EP2311852A1 (en) 2002-02-06 2011-04-20 Stasys Technologies, Inc. Anti-infarction molecules
AU2003253580A1 (en) * 2002-02-26 2003-11-17 University Of Minnesota Variants of nedd4l associated with hypertension and viral budding
PT1499545E (pt) 2002-04-04 2008-03-20 Monsanto Technology Llc Sistema automatizado de triagem, pesagem e recolha de matéria particulada
CA2495478A1 (en) 2002-08-05 2004-02-12 University Of Rochester Protein transducing domain/deaminase chimeric proteins, related compounds, and uses thereof
US20040214232A1 (en) * 2002-08-16 2004-10-28 Burke Martin D. Generation of skeletal diversity within a combinatorial library
US6878871B2 (en) 2002-09-05 2005-04-12 Nanosys, Inc. Nanostructure and nanocomposite based compositions and photovoltaic devices
MXPA06003184A (es) 2003-09-23 2006-06-23 Monsanto Technology Llc Sistema automatizado de alto rendimiento para analisis de semillas.
US7703238B2 (en) 2004-08-26 2010-04-27 Monsanto Technology Llc Methods of seed breeding using high throughput nondestructive seed sampling
MX2007002307A (es) 2004-08-26 2007-04-16 Monsanto Technology Llc Prueba automatizada de semillas.
WO2006108183A2 (en) 2005-04-05 2006-10-12 Corning Incorporated Label free biosensors and cells
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
EP2371843B1 (en) 2005-05-19 2014-09-17 THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by the Secretary, Department of Health and Human Services Functional epitopes of streptococcus pneumoniae psaA antigen and uses thereof
MX338235B (es) 2005-06-07 2016-04-08 Dsm Nutritional Products Ag Microorganismos eucarioticos para producir lipidos y antioxidantes.
US8080534B2 (en) 2005-10-14 2011-12-20 Phigenix, Inc Targeting PAX2 for the treatment of breast cancer
EP2189522A1 (en) 2005-10-14 2010-05-26 MUSC Foundation For Research Development Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
AU2006308863A1 (en) * 2005-10-31 2007-05-10 Janssen Pharmaceutica N.V. A polypeptide complex of TRPM8 and calmodulin and its uses thereof
US8028469B2 (en) 2006-03-02 2011-10-04 Monsanto Technology Llc Automated high-throughput seed sampler and methods of sampling, testing and bulking seeds
US7998669B2 (en) 2006-03-02 2011-08-16 Monsanto Technology Llc Automated contamination-free seed sampler and methods of sampling, testing and bulking seeds
GB0605584D0 (en) * 2006-03-20 2006-04-26 Olink Ab Method for analyte detection using proximity probes
EP3162454B1 (en) 2006-06-28 2019-04-24 Monsanto Technology LLC Small object sorting method
EP2082053B1 (en) * 2006-08-01 2016-04-13 DSM Nutritional Products AG Process for producing microbial oil comprising polyunsaturated fatty acids
EP2066812A4 (en) 2006-09-21 2010-04-28 Univ Rochester COMPOSITIONS AND METHODS RELATED TO PROTEIN SHIFT THERAPY FOR MYOTONE DYSTROPHY
EP2104516B1 (en) 2006-11-01 2015-01-07 University of Rochester Methods and compositions related to the structure and function of apobec3g
EP2097448A4 (en) 2006-12-22 2010-07-21 Univ Utah Res Found PROCEDURE FOR THE EVIDENCE OF EYE DISEASES AND SUFFERINGS AND THEIR TREATMENT
JP2010514839A (ja) 2007-01-03 2010-05-06 バーナム インスティテュート フォー メディカル リサーチ クロット結合化合物に関連する方法および組成物
EP2117576B1 (en) 2007-02-08 2014-04-16 University Of Utah Research Foundation Methods and compositions related to inhibition of viral entry
ES2428571T3 (es) 2007-05-31 2013-11-08 Monsanto Technology, Llc Clasificador de semillas
US8961412B2 (en) 2007-09-25 2015-02-24 Proteus Digital Health, Inc. In-body device with virtual dipole signal amplification
US8816095B2 (en) * 2008-08-15 2014-08-26 Georgetown University Na channels, disease, and related assays and compositions
US20120070443A1 (en) 2008-12-02 2012-03-22 University Of Utah Research Foundation Pde1 as a target therapeutic in heart disease
US10481167B2 (en) 2008-12-05 2019-11-19 C2N Diagnostics Methods for measuring concentrations of biomolecules
BR122013009559A2 (pt) 2009-04-28 2019-08-06 Proteus Digital Health, Inc. Marcadores de evento de ingerível altamente confiável e métodos para usar os mesmos
WO2011022502A1 (en) 2009-08-18 2011-02-24 Georgetown University Boronic acid compositions and methods related to cancer
EP2485768A1 (en) 2009-10-07 2012-08-15 Sanford-Burnham Medical Research Institute Methods and compositions related to clot-binding lipid compounds
JP2013515008A (ja) 2009-12-18 2013-05-02 サンフォード−バーナム メディカル リサーチ インスティテュート 凝血塊結合化合物に関連する方法および組成物
GB201004292D0 (en) * 2010-03-15 2010-04-28 Olink Ab Assay for localised detection of analytes
GB201101621D0 (en) 2011-01-31 2011-03-16 Olink Ab Method and product
CA2868735C (en) 2011-03-28 2020-02-25 University Of Utah Research Foundation D-peptide conjugates comprising a membrane localizing potency-enhancing cargo molecule for inhibiting hiv entry
PE20141562A1 (es) 2011-10-14 2014-11-12 Genentech Inc Anticuerpos anti-htra1 y metodos de uso
WO2013082307A1 (en) * 2011-12-02 2013-06-06 C2N Diagnostics Methods for measuring concentrations of biomolecules
GB201201547D0 (en) 2012-01-30 2012-03-14 Olink Ab Method and product
WO2014139980A1 (en) 2013-03-12 2014-09-18 Ventana Medical Systems, Inc. Proximity assay for in situ detection of targets
WO2014139979A1 (en) 2013-03-12 2014-09-18 Ventana Medical Systems, Inc. Quantum dot in situ hybridization
EP2970926B1 (en) 2013-03-13 2018-01-31 DSM Nutritional Products AG Engineering microorganisms
AU2015352625B2 (en) 2014-11-25 2019-07-25 Ventana Medical Systems, Inc. Proximity assays using chemical ligation and hapten transfer
GB201518655D0 (en) 2015-10-21 2015-12-02 Olink Ab Method for generating proximity probes
SI3368578T1 (sl) 2015-10-30 2021-08-31 F. Hoffmann-La Roche Ag Protitelesa proti HtrA1 in postopki uporabe
US12025615B2 (en) 2017-09-15 2024-07-02 Arizona Board Of Regents On Behalf Of Arizona State University Methods of classifying response to immunotherapy for cancer
US12357653B2 (en) 2017-12-15 2025-07-15 Flagship Pioneering Innovations Vi, Llc Compositions comprising circular polyribonucleotides and uses thereof
KR20210134716A (ko) 2019-03-01 2021-11-10 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 폴리리보뉴클레오티드의 전달을 위한 조성물, 방법, 및 키트
WO2020198403A2 (en) 2019-03-25 2020-10-01 Flagship Pioneering Innovations Vi, Llc Compositions comprising modified circular polyribonucleotides and uses thereof
WO2020252436A1 (en) 2019-06-14 2020-12-17 Flagship Pioneering Innovations Vi, Llc Circular rnas for cellular therapy
JP2022536951A (ja) 2019-06-19 2022-08-22 フラッグシップ パイオニアリング イノベーションズ シックス，エルエルシー 環状ポリリボヌクレオチドを投与する方法
WO2021067550A1 (en) 2019-10-02 2021-04-08 Arizona Board Of Regents On Behalf Of Arizona State University Methods and compositions for identifying neoantigens for use in treating and preventing cancer
US20230104113A1 (en) 2020-01-29 2023-04-06 Flagship Pioneering Innovations Vi, Llc Delivery of compositions comprising circular polyribonucleotides
BR112022025113A2 (pt) 2020-06-30 2022-12-27 Monsanto Technology Llc Sistemas automatizados para uso em separação de pequenos objetos, e métodos relacionados
EP4266991A4 (en) 2021-01-29 2025-01-01 The Regents of University of California IMPLANTABLE IMAGING DEVICES FOR IN VIVO IMAGING

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0474790T3 (da) * 1989-06-14 1997-07-07 Martek Corp Medier til cellevækst og fremgangsmåde til fremstilling deraf
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
CA2143848C (en) * 1992-10-01 2007-09-11 W. Clark Still Complex combinatorial chemical libraries encoded with tags

Also Published As

Publication number Publication date
EP0839152A1 (en) 1998-05-06
DK0839152T3 (da) 2002-07-08
DE69619825T2 (de) 2002-10-10
JPH11509086A (ja) 1999-08-17
ATE214396T1 (de) 2002-03-15
PT839152E (pt) 2002-09-30
WO1997000887A1 (en) 1997-01-09
DE69619825D1 (de) 2002-04-18
EP0839152B1 (en) 2002-03-13
US5741713A (en) 1998-04-21
CA2225313A1 (en) 1997-01-09
AU6180696A (en) 1997-01-22

Similar Documents

Publication Publication Date Title
ES2174075T3 (es) Librerias combinatorias de compuestos bioquimicos marcados y metodos para producir las mismas.
DE59708838D1 (de) Spiegelselektion und spiegelevolution von nucleinsäuren
ES2173187T3 (es) Sintesis de bibliotecas combinatoriales.
DK0933082T3 (da) Fremgangsmåde til manipulation af celledifferentiering
ES2143793T3 (es) Utilizacion de la resistencia magnetica nuclear para identificar ligandos con biomoleculas blanco.
WO1996004557A3 (en) Target specific screens and their use for discovering small organic molecular pharmacophores
DE60226486D1 (de) Selbstanordnende moleküle
ATE343791T1 (de) Verfahren zur sichtung einer bibliothek von chemischen verbindungen
PT990047E (pt) Metodos e composicoes para a analise de acidos nucleicos por espectroscopia de massa.
ATE346296T1 (de) Kombinatorische, komplexe kohlenhydrat- bibliotheken und verfahren zur herstellung und zum gebrauch davon
DE69942701D1 (de) Kontinuierliche in vitro-evolution.
ATE216777T1 (de) Affinitäts-selektion von liganden mittels massenspektroskopie
PT868427E (pt) Metodos para identificar compostos que se ligam a um alvo
BR9407422A (pt) Kit de ensaio
ATE545019T1 (de) Mikrofluidisches extraktionsverfahren
DE69619410D1 (de) Zusammensetzungen für nukleinsäure zielrichtung
DK0774116T3 (da) Fremgangsmåde til screening af biblioteker af forbindelser
CA2350141A1 (en) A method for determining a mimotope sequence
WO2002014858A3 (de) Verfahren zur herstellung und ermittlung geeigneter effektoren von zielmolekülen mit substanzbibliotheken
ATE408816T1 (de) Verfahren zur bestimmung sekundärer molekülmodifikationen unter verwendung von arrays
ITRM930391A0 (it) Metodologia per la selezione di sequenze amminoacidiche, che interferiscono con il legame ligando-recettore, mediante librerie combinatoriali di peptidi sintetici sintetici multimerici.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 839152

Country of ref document: ES